These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3826671)

  • 1. Postpartum uterine atony after intravenous dantrolene.
    Weingarten AE; Korsh JI; Neuman GG; Stern SB
    Anesth Analg; 1987 Mar; 66(3):269-70. PubMed ID: 3826671
    [No Abstract]   [Full Text] [Related]  

  • 2. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
    Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
    Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
    Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
    Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
    Free CW; Jaimon MP
    N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of postpartum uterine atony with prostaglandin E2 vaginal suppositories.
    Hertz RH; Sokol RJ; Dierker LJ
    Obstet Gynecol; 1980 Jul; 56(1):129-30. PubMed ID: 6966776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of postpartum uterine atony by intramyometrial prostaglandin.
    Bruce SL; Paul RH; Van Dorsten JP
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):47S-50S. PubMed ID: 6979727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of postpartum uterine atony.
    Ferland RJ; Adler LM
    R I Med J (1976); 1990 Dec; 73(12):626-7. PubMed ID: 2293317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sodium dantrolene].
    Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
    Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
    [No Abstract]   [Full Text] [Related]  

  • 9. Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant.
    Shime J; Gare D; Andrews J; Britt B
    Am J Obstet Gynecol; 1988 Oct; 159(4):831-4. PubMed ID: 3177531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General anesthesia in a malignant hyperthermia susceptible patient.
    Jones JE; Dierdorf SF; Clapp DW
    J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
    [No Abstract]   [Full Text] [Related]  

  • 11. [Emergency postpartum hysterectomy. A study over 5 years].
    Deppe G; Baumann P; Malviya VK; Cotton DB
    Wien Klin Wochenschr; 1994; 106(18):581-3. PubMed ID: 7992496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
    Ruhland G; Hinkle AJ
    Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
    [No Abstract]   [Full Text] [Related]  

  • 13. [Postpartum atony].
    Husslein P
    Arch Gynecol Obstet; 1991; 249 Suppl():S33-7. PubMed ID: 1665688
    [No Abstract]   [Full Text] [Related]  

  • 14. The MFMU Cesarean Registry: uterine atony after primary cesarean delivery.
    Rouse DJ; Leindecker S; Landon M; Bloom SL; Varner MW; Moawad AH; Spong CY; Caritis SN; Harper M; Wapner RJ; Sorokin Y; Miodovnik M; O'Sullivan MJ; Sibai BM; Langer O;
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1056-60. PubMed ID: 16157111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
    Watson CB; Reierson N; Norfleet EA
    Anesthesiology; 1986 Sep; 65(3):312-4. PubMed ID: 3752576
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prostaglandins in uterine atony].
    Husslein P
    Gynakologe; 1991 Aug; 24(4):198-201. PubMed ID: 1937160
    [No Abstract]   [Full Text] [Related]  

  • 18. [Postpartum atony].
    Faridi A; Rath W
    Z Geburtshilfe Neonatol; 1996; 200(2):76-8. PubMed ID: 8767294
    [No Abstract]   [Full Text] [Related]  

  • 19. [15(S)-15-methyl-prostaglandin F2 alpha. A potent synthetic prostaglandin F2 alpha for treatment of postpartum atony].
    Høgdall EV; Høgdall CK
    Ugeskr Laeger; 1991 Nov; 153(46):3260-2. PubMed ID: 1957386
    [No Abstract]   [Full Text] [Related]  

  • 20. Dantrolene for malignant hyperthermia during anesthesia.
    Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.